Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-02 · accession 0001614740-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-02-02 | MIRM | Peetz Christopher | CEO, Dir | S - Sale | $103.30 | -9,108 | 160.3K | -5% | -$940.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | S | D | 9,108 | $103.30 | 160,294 | D | — | — |